Dana Investment Advisors Inc. Has $7.78 Million Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Dana Investment Advisors Inc. reduced its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 5.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 99,631 shares of the company’s stock after selling 5,758 shares during the period. Dana Investment Advisors Inc. owned 0.20% of Prestige Consumer Healthcare worth $7,780,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Kestra Investment Management LLC bought a new position in shares of Prestige Consumer Healthcare in the 4th quarter valued at about $27,000. Huntington National Bank boosted its position in Prestige Consumer Healthcare by 39.9% during the third quarter. Huntington National Bank now owns 635 shares of the company’s stock valued at $46,000 after purchasing an additional 181 shares during the last quarter. International Assets Investment Management LLC grew its stake in Prestige Consumer Healthcare by 7,112.5% in the third quarter. International Assets Investment Management LLC now owns 1,154 shares of the company’s stock valued at $83,000 after purchasing an additional 1,138 shares in the last quarter. Covestor Ltd increased its position in shares of Prestige Consumer Healthcare by 95.6% during the 3rd quarter. Covestor Ltd now owns 1,338 shares of the company’s stock worth $96,000 after purchasing an additional 654 shares during the last quarter. Finally, GAMMA Investing LLC raised its stake in shares of Prestige Consumer Healthcare by 18.9% during the 4th quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock worth $108,000 after purchasing an additional 220 shares in the last quarter. 99.95% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research firms recently weighed in on PBH. DA Davidson raised their target price on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a research note on Friday, February 7th. StockNews.com raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, January 24th. Raymond James upgraded shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research note on Thursday, December 19th. Oppenheimer raised their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a research note on Thursday, February 13th. Finally, Canaccord Genuity Group boosted their price target on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $92.60.

Prestige Consumer Healthcare Price Performance

Shares of PBH opened at $85.67 on Thursday. The company’s 50-day moving average is $80.43 and its 200-day moving average is $77.57. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20. The firm has a market capitalization of $4.24 billion, a PE ratio of 20.06, a PEG ratio of 2.69 and a beta of 0.50. Prestige Consumer Healthcare Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $88.36.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. Equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.